Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer, Castration Resistant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02282644
What this trial is testing

Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 17
Not applicableStudy completedNCT04962919
What this trial is testing

Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Latin American Cooperative Oncology Group 584
Testing effectiveness (Phase 2)WithdrawnNCT00577980
What this trial is testing

Testosterone in Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center
Early research (Phase 1)Ended earlyNCT05047536
What this trial is testing

KZR-261 in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced/Metastatic Solid Tumor
Kezar Life Sciences, Inc. 61
Testing effectiveness (Phase 2)Looking for participantsNCT06084338
What this trial is testing

Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc

Who this might be right for
Prostate Cancer
VA Office of Research and Development 60
Early research (Phase 1)Not Yet RecruitingNCT07244393
What this trial is testing

Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Cellbion Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT04363164
What this trial is testing

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Who this might be right for
Castration Resistant Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 150
Early research (Phase 1)Study completedNCT01085422
What this trial is testing

A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AbbVie (prior sponsor, Abbott) 35
Very early researchStudy completedNCT03071328
What this trial is testing

INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Urothelial CarcinomaMetastatic Renal Cell Carcinoma
Duke University 10
Testing effectiveness (Phase 2)Study completedNCT01942837
What this trial is testing

Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 67
Not applicableWithdrawnNCT02905201
What this trial is testing

A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Testing effectiveness (Phase 2)Ended earlyNCT05075577
What this trial is testing

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Who this might be right for
Prostate Cancer
ESSA Pharmaceuticals 77
Large-scale testing (Phase 3)Study completedNCT05547386
What this trial is testing

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Mayo Clinic 163
Early research (Phase 1)Study completedNCT03737370
What this trial is testing

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer
Tufts Medical Center 43
Testing effectiveness (Phase 2)Study completedNCT01637402
What this trial is testing

A Phase II Study of Increased-Dose Abiraterone Acetate in Patients With Castration Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Terence Friedlander, MD 41
Early research (Phase 1)UnknownNCT02502994
What this trial is testing

Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC

Who this might be right for
Castration Resistant Prostate Cancer
Norio Nonomura 12
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Testing effectiveness (Phase 2)Study completedNCT03643107
What this trial is testing

Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer Patients
Allarity Therapeutics 15
Large-scale testing (Phase 3)Study completedNCT01193257
What this trial is testing

Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 1,099
Next Page